In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

The results indicate that β-glucans can target the immune system and modulate pro-inflammatory responses. Their potential to suppress allergic reactions and offer new approaches to allergy treatment ...

The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

LINDA M. LIAU NEUROSURGERY Chair, Department of Neurosurgery at UCLA Health; Professor and Director, UCLA Brain Tumor Center; ...